PCEC publishes hundreds of abstracts at major medical meetings around the world every year.  Here are some of our favorites.....


Reaching Men to Participate in a Health Screening Program

Medical Androgen Deficiency (MAD) Screening Questionnaire: A Simplified Tool to Indentify Hypogonadal Men

Impact of the Controversy of Prostate Cancer Screening on Participation in Free Screening

BJUI Robert J. Krane Awarded to PCEC for Prostate cancer danger zone study 

Repeat PSA and DRE testing in a Prostate Cancer Screening Environment

Relationship Between Serum Testosterone, BMI, Fat Consumption, and Exercise

American Urological Association Symptom Score Nocturia Question As An Independent Indicator of BPH in a Screening Population

Urine PCA3 Testing for the Early Detection of Prostate Cancer.Feasibility, Test Performance, and Age & Race Assoc. Compared to Serum PSA in a Multi-Ethnic Population over Four Years

Prostate Cancer and Men's Health Screening: Comparison of the Screening Populations from 2003 to 2009

Associaton of Testorsterone Replacement Therapies to Average Testosterone in a Screening Population

Prevalence and Predictors of Supplement Use in a Population of Adult Men: A Potential Cancer

Significant Differences in Mean Testosterone by United States Geographic Region in a Screening Population

Association of Statin Use to Serum Prostate Specific Antigen Levels in a Screening Population

Total Testosterone not Associatied with Lower Urinary Tract Symptoms in a Prostate Cancer Screening Population

Use of a 1.5 PSA Threshold to Identify Increased Risk for Prostate Cancer in a Screening Population